[HTML][HTML] Hsp27 (HspB1) and αB-crystallin (HspB5) as therapeutic targets

AP Arrigo, S Simon, B Gibert, C Kretz-Remy, M Nivon… - FEBS letters, 2007 - Elsevier
AP Arrigo, S Simon, B Gibert, C Kretz-Remy, M Nivon, A Czekalla, D Guillet, M Moulin
FEBS letters, 2007Elsevier
Hsp27 and αB-crystallin are molecular chaperones that are constitutively expressed in
several mammalian cells, particularly in pathological conditions. These proteins share
functions as diverse as protection against toxicity mediated by aberrantly folded proteins or
oxidative-inflammation conditions. In addition, these proteins share anti-apoptotic properties
and are tumorigenic when expressed in cancer cells. This review summarizes the current
knowledge about Hsp27 and αB-crystallin and the implications, either positive or …
Hsp27 and αB-crystallin are molecular chaperones that are constitutively expressed in several mammalian cells, particularly in pathological conditions. These proteins share functions as diverse as protection against toxicity mediated by aberrantly folded proteins or oxidative-inflammation conditions. In addition, these proteins share anti-apoptotic properties and are tumorigenic when expressed in cancer cells. This review summarizes the current knowledge about Hsp27 and αB-crystallin and the implications, either positive or deleterious, of these proteins in pathologies such as neurodegenerative diseases, myopathies, asthma, cataracts and cancers. Approaches towards therapeutic strategies aimed at modulating the expression and/or the activities of Hsp27 and αB-crystallin are presented.
Elsevier